Showing results (1311-1320 of 1,825) with videos related to
Sort By:
Pageof 183
British Journal of Haematology|April 10, 2021
Second allogeneic haematopoietic cell transplantation using HLA-matched unrelated versus T-cell replete haploidentical donor and survival in relapsed acute myeloid leukaemiaMohamed A Kharfan-Dabaja, Myriam Labopin, Eolia Brissot, et al.The European Respiratory Journal|December 8, 2025
Health-Related Quality of Life in Childhood Interstitial Lung DiseaseMatthias Griese, Mandy Niemitz, Katrin Erlewein, et al.Leukemia|June 25, 2024
How risky is a second allogeneic stem cell transplantation?Olaf Penack, Mouad Abouqateb, Christophe Peczynski, et al.Bone Marrow Transplantation|September 29, 2019
Allogeneic stem-cell transplantation with sequential conditioning in adult patients with refractory or relapsed acute lymphoblastic leukemia: a report from the EBMT Acute Leukemia Working PartyAbdul Hamid Bazarbachi, Rama Al Hamed, Myriam Labopin, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 18, 2011
Plerixafor for autologous peripheral blood stem cell mobilization in patients previously treated with fludarabine or lenalidomideFlorent Malard, Nicolaus Kröger, Ian H Gabriel, et al.Bone Marrow Transplantation|February 23, 2022
Impact of the SARS-CoV-2 pandemic on hematopoietic cell transplantation and cellular therapies in Europe 2020: a report from the EBMT activity surveyJakob R Passweg, Helen Baldomero, Christian Chabannon, et al.Acta Oncologica (Stockholm, Sweden)|July 2, 2019
LINAC based stereotactic radiosurgery for multiple brain metastases: guidance for clinical implementationDianne Hartgerink, Ans Swinnen, David Roberge, et al.The European Journal of Neuroscience|January 28, 2005
Specific pathophysiological functions of JNK isoforms in the brainStephan Brecht, Rainer Kirchhof, Ansgar Chromik, et al.Plos One|October 12, 2013
Comparison of allogeneic stem cell transplantation and non-transplant approaches in elderly patients with advanced myelodysplastic syndrome: optimal statistical approaches and a critical appraisal of clinical results using non-randomized dataRonald Brand, Hein Putter, Anja van Biezen, et al.Blood Cancer Journal|March 15, 2024
PTCy versus ATG as graft-versus-host disease prophylaxis in mismatched unrelated stem cell transplantationOlaf Penack, Mouad Abouqateb, Christophe Peczynski, et al.Pageof 183